Post-ocular surgery, loteprednol delivers pain relief
June 1st 2010A post hoc analysis of data collected in two published, pivotal clinical trials demonstrates that in addition to its efficacy for treating inflammation following ocular surgery, loteprednol etabonate ophthalmic suspension 0.5% provides statistically significant relief of postoperative pain and other symptoms.
Difluprednate improves results after cataract surgery
June 1st 2010Pre- and postoperative treatment with the potent corticosteroid difluprednate ophthalmic solution 0.05% significantly improves outcomes after cataract surgery compared with use of prednisolone acetate ophthalmic suspension 1% and so results in patient satisfaction.
Moxifloxacin demonstrates prophylactic effectiveness
June 1st 2010In a quantitative determination of the prophylactic effectiveness of two commercially available ocular fluoroquiinolones within the anterior chamber of rabbit eyes, moxifloxacin ophthalmic solution 0.5% demonstrated significantly greater bacterial killing than besifloxacin ophthalmic suspension 0.6%.
Medical groups do not support Medicare fix
June 1st 2010As yet another deadline challenges Congress to avert a 21.3% pay cut to physicians who treat Medicare and Medicaid patients, groups representing the nation's physicians say they do not support a proposal that fails to change the formula behind the cut.
Stronger gatifloxacin OK'd to address pathogen resistance
June 1st 2010The availability of a new formulation of gatifloxacin ophthalmic solution containing 0.5% active ingredient will provide ophthalmologists with a valuable option for addressing the growing problem of resistance among some important ocular pathogens.
Study: levofloxacin induced least toxicity, apoptosis
June 1st 2010In a study performed to evaluate and compare preserved versus unpreserved fluoroquinolone antibiotics, cell culture assays demonstrated some degree of toxicity and elevated induction of apoptosis in each of three commercially available topical ocular fluoroquinolone antibiotics.
Dual-optic accommodating intraocular lens maintains functional performance over time
May 15th 2010Results from 3 years of follow-up in patients with the dual-optic accommodating IOL implanted bilaterally show this second-generation accommodating technology provides adequate and stable functional vision at all distances.
Judge rejects CIBA Vision's attempt to block Johnson & Johnson contact lens sales
May 15th 2010J&J Vision Care may continue selling its Acuvue Oasys contact lenses even though their manufacturing infringes CIBA Vision's patent, in order to protect "millions of innocent contact lens wearers" who would have to be refitted with a different brand, a federal judge has ruled.
Monofocal intraocular lens sets new standard
May 15th 2010With the FDA clearance of a new monofocal pseudophakic posterior chamber IOL comes the availability of a novel implant designed with a host of features that result in outstanding outcomes and that make the lens a premier option for most cataract surgery patients.